 |
|
 |
 |
Acute/Chronic RN —NY
A great opportunity to work 13 weeks in a scenic and historic town. One-year dialysis experience needed. Fresenius K machines. |
 |
|
 |
Chronic RN — MA
8-week opportunity in a brand new facility in a progressive community. Charge experience needed. Fresenius K machines. |
|
|
 |
Chronic/Acute RN — NJ
Great 3 to 12 week opportunities for bedside and acute room treatment in an entertainment and leisure hub. ACLS required. |
|
|
 |
Chronic/Acute RN —RI
4 to 10 week assignments in a sophisticated and culturally vibrant city. Fresenius K machines. ICU, CNN and Med Surg experience a plus.
|
|
|
 |
Acute RN — CA
A great opportunity to work 4 to 10 week assignment in Southern California with proximity to large metro areas. Fresenius K machines. |
|
|
 |
Chronic RN — TX
A great opportunity for a 4 to 10 week assignment in a colorful, vibrant and charming city. Fresenius H and K machines.
|
|
|
Search all dialysis jobs now
|
|
|
|
 |
CMS Expects 1.2 Percent Increase in Dialysis Patient Co-Pays
Dialysis patients using Medicare can expect to see a 1.2 percent increase in their co-insurance payments largely due to the inclusion of laboratory tests into the new end-stage renal disease payment bundle, according to an analysis by the Centers for Medicare & Medicaid Services.
"The patient's share of costs is likely to increase for most everybody because the 20 percent coinsurance for the bundle compared to the composite rate they pay now is going to be more because there are more services in the bundle," said Tonya Saffer, deputy director, Dialysis Patient Citizens. "For patients, who have a higher than average utilization of previously separately billable items like ESAs, CMS has theorized that there is a chance that overall their coinsurance or co-pays could be lower."
Under the current system, Medicare beneficiaries on dialysis pay 20 percent of the dialysis base payment plus 20 percent of ESRD-related separately billable drugs, such as Amgen's Epogen used to treat anemia. However, patients currently do not pay co-insurance on separately billable lab tests.
The new ESRD Prospective Payment System, released in July, bundles separately billable drugs, labs and the existing payments for dialysis services into one payment per treatment. CMS will pay for 80 percent of each treatment and patients will be responsible for the remaining 20 percent.
"As the beneficiary will be responsible for the co-insurance on the laboratory tests, we estimate they will have a 1.2 percent increase in their payments," CMS wrote in the final rule.
An excerpt from: "CMS Expects 1.2 Percent Increase in Dialysis Patient Co-Pays," by Keith Chartier. Renal Business Today. Read the full article at: http://www.renalbusiness.com/
|
|
|
|
|
|
